{"id":"110f25a7-ae84-4bb3-8b07-29708b8f8133","kind":"companies","code":"UB-C11493","name":"PsyLabs","nameBasis":"source-english","summary":"Licensed pharmaceutical-grade psychedelics supply","description":"Licensed Cultivation and Production Facility - International Supplier of Pharmaceutical Grade Psychoactive Compounds","country":null,"category":null,"originalName":"PsyLabs","eventDate":null,"website":"https://psylabs.life/","sourceUpdatedAt":"2026-10-25T00:00:00.000Z","englishUpdatedAt":"2026-11-01T02:03:52.347Z","reviewedAt":"2026-11-01T02:03:52.347Z","snapshotAt":"2026-11-01T00:40:31.077Z","sourceHash":"bbe1fa2e7a79b0666eee7702aec918a334e6aa96843bd4f1fdaad8a2a910cbfb","companyId":null,"foundedYear":null,"logoUrl":null,"originalText":"Licensed pharmaceutical-grade psychedelics supply\n\nLicensed Cultivation and Production Facility - International Supplier of Pharmaceutical Grade Psychoactive Compounds","sources":[],"related":[{"id":"af51df93-6d72-46c9-9cd6-ecbf319c12d6","kind":"news","code":"af51df93-6d72-46c9-9cd6-ecbf319c12d6","name":"PsyLabs closes $2,599,896 other financing","nameBasis":"translated-title","summary":"On 2026-10-21, per fireround, PsyLabs closes $2,599,896 other financing.","description":"","country":null,"category":null,"originalName":"PsyLabs 完成 2,599,896美元 other 融资","eventDate":"2026-10-21T00:00:00.000Z","website":"https://www.globenewswire.com/news-release/2026/10/21/3385368/0/en/psyence-biomed-completes-psylabs-investment-as-ibogaine-milestones-are-met.html","sourceUpdatedAt":"2026-10-25T21:00:17.852Z","englishUpdatedAt":"2026-11-01T02:06:57.507Z","reviewedAt":"2026-11-01T02:06:57.507Z","snapshotAt":"2026-10-26T00:41:48.695Z","sourceHash":"59c4fb23560321aa04b10af5ed62028cc0b5b652379ba94ea5f5f05bd30e4e22","companyId":"110f25a7-ae84-4bb3-8b07-29708b8f8133","foundedYear":null,"logoUrl":null,"transactionConsiderationUsd":null,"considerationLabel":null,"amountEstimateUsd":2599896,"fundingEstimateUsd":null,"fundingEstimateLabel":null,"path":"/news/af51df93-6d72-46c9-9cd6-ecbf319c12d6"}],"finance":{"funding":{"metric":"funding","count":1,"latest":null,"years":[],"points":[],"linePoints":[],"conflictGroups":0,"omittedRecordCount":1,"records":[{"id":"af51df93-6d72-46c9-9cd6-ecbf319c12d6","date":"2026-10-21T00:00:00.000Z","round":null,"amountText":"2,599,896美元","estimateUsd":null,"estimateLabel":null,"estimateNote":null,"considerationUsd":null,"considerationLabel":null,"investors":null,"institutions":[],"newsUrl":"https://www.globenewswire.com/news-release/2026/10/21/3385368/0/en/psyence-biomed-completes-psylabs-investment-as-ibogaine-milestones-are-met.html","evidence":{"headline":"PsyLabs closes $2,599,896 other financing","brief":"On 2026-10-21, per fireround, PsyLabs closes $2,599,896 other financing.","basis":"translated-source-brief","newsPath":"/news/af51df93-6d72-46c9-9cd6-ecbf319c12d6","sourceCount":1}}],"totalRaised":null},"valuation":{"metric":"valuation","count":1,"latest":null,"years":[],"points":[],"linePoints":[],"conflictGroups":0,"omittedRecordCount":1,"records":[{"id":"af51df93-6d72-46c9-9cd6-ecbf319c12d6","date":"2026-10-21T00:00:00.000Z","round":null,"amountText":null,"estimateUsd":null,"estimateLabel":null,"estimateNote":null,"considerationUsd":null,"considerationLabel":null,"investors":null,"institutions":[],"newsUrl":"https://www.globenewswire.com/news-release/2026/10/21/3385368/0/en/psyence-biomed-completes-psylabs-investment-as-ibogaine-milestones-are-met.html","evidence":{"headline":"PsyLabs closes $2,599,896 other financing","brief":"On 2026-10-21, per fireround, PsyLabs closes $2,599,896 other financing.","basis":"translated-source-brief","newsPath":"/news/af51df93-6d72-46c9-9cd6-ecbf319c12d6","sourceCount":1}}]},"revenue":{"metric":"revenue","count":0,"latest":null,"years":[],"points":[],"linePoints":[],"conflictGroups":0,"omittedRecordCount":0,"records":[]}},"events":[{"id":"af51df93-6d72-46c9-9cd6-ecbf319c12d6","kind":"funding","eventDate":"2026-10-21T00:00:00.000Z","revenueDate":null,"round":null,"amountText":"2,599,896美元","valuationText":null,"revenueText":"","cumulativeFundingText":"","amountEstimateUsd":null,"valuationEstimateUsd":null,"revenueEstimateUsd":null,"cumulativeFundingEstimateUsd":null,"transactionConsiderationUsd":null,"considerationLabel":null,"investors":null,"newsUrl":"https://www.globenewswire.com/news-release/2026/10/21/3385368/0/en/psyence-biomed-completes-psylabs-investment-as-ibogaine-milestones-are-met.html","newsTypes":["融资"],"institutions":[],"roundName":null,"amountLabel":null,"valuationLabel":null,"revenueLabel":null,"cumulativeFundingLabel":null}],"team":[],"productsRelated":[],"investors":[],"path":"/companies/psylabs","structured":{"city":null,"country":null,"location":null,"role":null,"category":null,"company":null},"definition":"PsyLabs is a company.","summaryBasis":"translated","thin":false,"canonical":"https://uniquebase.ai/companies/psylabs"}